Vittal Vasista, Chief Financial Officer at REGENXBIO Inc. (RGNX), sold 9,132 shares at $30.01 ($274K) on 2022-07-13, disclosed to the SEC on 2022-07-15.
Open-market sale of $274k RGNX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.01 | 4,332 | $130K | 47.4% |
| 2 | $30.01 | 4,332 | $130K | 47.4% |
| 3 | $30.00 | 468 | $14K | 5.1% |
| Total | $30.01 avg | 9,132 | $274K | 100% |
| Filing → |
| RGNX | SELL | 2022-08-03 | $75K | — | Filing → |
| RGNX | SELL | 2021-01-20 | $13K | — | Filing → |
| RGNX | SELL | 2021-01-14 | $1.3M | — | Filing → |